Join
Live feed
·
PRReleasevia Quantisnow
AVROBIO Inc. logo

AVROBIO to Present New Data from Phase 1/2 Clinical Trial in Cystinosis at WORLDSymposium™ 2022

ByQuantisnow·Wall Street's wire, on your screen.
AVRO· AVROBIO Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AVRO (AVROBIO Inc.) and more on Quantisnow.